Assignee
UNITED THERAPEUTICS CORP
US·104 granted patents·84 pending applications·2,643 citations·filing 1998–2025
Top patents by PatentIndex Score
188 records- 0199US9050311B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2013·Granted Jun 9, 2015·59 cites·11 claims
- 0299US6700025B2Process for stereoselective synthesis of prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2001·Granted Mar 2, 2004·121 cites·13 claims
- 0398US11292758B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2021·Granted Apr 5, 2022·3 cites·12 claims
- 0498US9624156B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Apr 18, 2017·30 cites·31 claims
- 0598US9593061B2Synthesis of intermediates for producing prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 14, 2017·13 cites·22 claims
- 0698US9422223B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Aug 23, 2016·44 cites·16 claims
- 0798US9278901B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 8, 2016·47 cites·12 claims
- 0898US9156786B2Process to prepare treprostinil, the active ingredient in remodulin®UNITED THERAPEUTICS CORP·Filed 2013·Granted Oct 13, 2015·44 cites·15 claims
- 0998US7544713B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2006·Granted Jun 9, 2009·108 cites·26 claims
- 1098US7417070B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2004·Granted Aug 26, 2008·155 cites·3 claims
- 1198US7384978B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2006·Granted Jun 10, 2008·138 cites·14 claims
- 1297US9878972B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2016·Granted Jan 30, 2018·19 cites·34 claims
- 1397US9199908B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2014·Granted Dec 1, 2015·46 cites·11 claims
- 1497US8748657B2Process to prepare treprostinilUNITED THERAPEUTICS CORP·Filed 2013·Granted Jun 10, 2014·29 cites·7 claims
- 1597US8350079B2Treprostinil formulationUNITED THERAPEUTICS CORP·Filed 2009·Granted Jan 8, 2013·66 cites·11 claims
- 1697US8349892B2Solid formulations of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2010·Granted Jan 8, 2013·70 cites·33 claims
- 1797US6528688B2Prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2002·Granted Mar 4, 2003·95 cites·12 claims
- 1897US6441245B1Process for stereoselective synthesis of prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2000·Granted Aug 27, 2002·118 cites·10 claims
- 1996US11839631B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2020·Granted Dec 12, 2023·3 cites·10 claims
- 2096US11839596B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2021·Granted Dec 12, 2023·3 cites·7 claims
- 2196US11141393B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Oct 12, 2021·9 cites·10 claims
- 2296US10716793B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2020·Granted Jul 21, 2020·11 cites·8 claims
- 2396US10080730B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2014·Granted Sep 25, 2018·23 cites·11 claims
- 2496US10076505B2Inhalation formulations of TreprostinilUNITED THERAPEUTICS CORP·Filed 2017·Granted Sep 18, 2018·14 cites·7 claims
- 2596US9713599B2Parenteral formulations of treprostinilUNITED THERAPEUTICS CORP·Filed 2015·Granted Jul 25, 2017·18 cites·5 claims
- 2696US9701611B2Salts of treprostinilUNITED THERAPEUTICS CORP·Filed 2016·Granted Jul 11, 2017·8 cites·38 claims
- 2796US7879909B2Use of Treprostinil to treat neuropathic diabetic foot ulcersUNITED THERAPEUTICS CORP·Filed 2005·Granted Feb 1, 2011·63 cites·21 claims
- 2896US6803386B2Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancerUNITED THERAPEUTICS CORP·Filed 2002·Granted Oct 12, 2004·89 cites·16 claims
- 2995US11826328B2Stable treprostinil prodrugsUNITED THERAPEUTICS CORP·Filed 2021·Granted Nov 28, 2023·2 cites·10 claims
- 3095US10947177B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2019·Granted Mar 16, 2021·3 cites·48 claims
- 3195US9758465B2Controlled release pharmaceutical formulationsUNITED THERAPEUTICS CORP·Filed 2014·Granted Sep 12, 2017·24 cites·16 claims
- 3295US9102660B2Process of making prostacyclin compounds with linker thiol and pegylated formsUNITED THERAPEUTICS CORP·Filed 2014·Granted Aug 11, 2015·34 cites·23 claims
- 3395US7999007B2Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using sameUNITED THERAPEUTICS CORP·Filed 2008·Granted Aug 16, 2011·52 cites·26 claims
- 3495US6756033B2Method for delivering benzindene prostaglandins by inhalationUNITED THERAPEUTICS CORP·Filed 2002·Granted Jun 29, 2004·124 cites·10 claims
- 3595US6521212B1Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalationUNITED THERAPEUTICS CORP·Filed 2000·Granted Feb 18, 2003·149 cites·12 claims
- 3695US6242482B1Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failureUNITED THERAPEUTICS CORP·Filed 2000·Granted Jun 5, 2001·84 cites·51 claims
- 3794US11723887B2Process to prepare treprostinil, the active ingredient in Remodulin®UNITED THERAPEUTICS CORP·Filed 2019·Granted Aug 15, 2023·2 cites·11 claims
- 3894US10494327B2Controlled release pharmaceutical formulationsUNITED THERAPEUTICS CORP·Filed 2017·Granted Dec 3, 2019·11 cites·16 claims
- 3994US9593066B2Process to prepare treprostinil, the active ingredient in remodulin®UNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 14, 2017·9 cites·10 claims
- 4094US8653137B2Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using sameUNITED THERAPEUTICS CORP·Filed 2013·Granted Feb 18, 2014·34 cites·13 claims
- 4194US7199157B2Use of treprostinil to improve kidney functionsUNITED THERAPEUTICS CORP·Filed 2004·Granted Apr 3, 2007·120 cites·13 claims
- 4294US6809223B2Process for stereoselective synthesis of prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2003·Granted Oct 26, 2004·121 cites·4 claims
- 4393US11634443B2Treprostinil prodrugsUNITED THERAPEUTICS CORP·Filed 2020·Granted Apr 25, 2023·2 cites·16 claims
- 4493US10376525B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2016·Granted Aug 13, 2019·13 cites·4 claims
- 4593US10071123B2Treatment of pulmonary arterial hypertension with mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Sep 11, 2018·21 cites·3 claims
- 4693US10016463B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Jul 10, 2018·19 cites·16 claims
- 4793US9988334B2Salts of treprostinilUNITED THERAPEUTICS CORP·Filed 2017·Granted Jun 5, 2018·3 cites·15 claims
- 4893US9604901B2Process to prepare treprostinil, the active ingredient in Remodulin®UNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 28, 2017·7 cites·9 claims
- 4993US7715905B2Cooperative processing with mobile monitoring device and computer systemUNITED THERAPEUTICS CORP·Filed 2005·Granted May 11, 2010·89 cites·26 claims
- 5093US2025002442A1Synthesis of intermediates for producing prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
Showing the top 50 of 188 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when UNITED THERAPEUTICS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →